CBOE: Stock thesis & analysis
As of 09-01-2026
📁 From our research archive: this thesis was generated on 09-01-2026 and may not reflect our current view. See the latest research →
CBOE is a high-quality exchange franchise — 26.3% ROE, 34.6% operating margin, durable options-trading moat — but P/FCF of 46x and a valuation score of 36/100 leave little margin of safety at $300.20. Smart-money confirmation is thin (2 funds holding, persistence 2 quarters) — under-followed, likely because exchange/financial-infrastructure names of this size sit outside many mid-cap mandates rather than any fragility signal, but that also means there's no institutional tailwind to lean on. With HY spreads flagging a late-cycle warning and the stock trading at a rich multiple with no near-term catalyst, this is a name to like on a pullback, not chase here.
Catalysts to watch
- Q3 2026 earnings (expected late October 2026) — volume/margin trajectory update
- Potential volatility regime shift (VIX mean reversion) boosting trading volumes
- Further analyst coverage initiation following recent Barclays Overweight/TD Cowen Hold initiations
Key risks
- Valuation embeds aggressive expectations relative to trading-volume growth normalization
- Thin institutional confirmation (2 funds) limits corroborating conviction signal
- Late-cycle credit conditions could compress multiples across financial infrastructure names
- Options/futures volume is cyclical and sensitive to volatility regime shifts (VIX currently low at 15)
What would change the view
- Stock breaks below $270.00
- Op margin falls below 30% for 2 consecutive quarters
- P/FCF expands further past 55x without a commensurate acceleration in FCF growth